TG Therapeutics' low P/S ratio may be due to investor skepti...

TG Therapeutics' low P/S ratio may be due to investor skepticism about its future revenue performance. The company's inferior revenue outlook compared to the industry is contributing to its low P/S ratio. Investors feel the potential for revenue improvement doesn't justify a higher P/S ratio.